glutathione and triple negative breast cancer Frontiers Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven
Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple negative breast cancer treatment ScienceDirect Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3





